Skip to main content
Back
Watch Compare

TuHURA Biosciences, Inc./NV

Data quality: 100%
HURA
NASDAQ Manufacturing Chemicals
$2.27
▲ $0.31 (15.82%)
Mkt Cap: 122.39 M
Price
$1.93
Mkt Cap
122.39 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -27.71 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-165.91%
Below sector avg (-54.44%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.40
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-4.07 | -3.91
Below sector avg (-1.49)
P/B Ratio7.29
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -4.1 -1.5
P/B 7.3 1.6
ROE % -165.9 -54.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Analyst Price Target

4 analysts
Buy
Current
$2.27
+268.9%
Target
$8.38
$7.50
$8.00
$10.00
Forecast
Forward P/E -3.91
Forward EPS -$0.58
Est. Revenue 22.56 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.58
-$0.58 – -$0.58
 22.56 M 2
FY2026 -$0.51
-$0.59 – -$0.45
 0.0 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.12 -$0.16 -32.3%
Q32025 -$0.15 -$0.14 +6.7%
Q22025 -$0.14 -$0.21 -55.6%
Q12025 -$0.11 -$0.15 -36.4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -30.05 M
ROE -165.91% ROA -99.64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -27.71 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.40
Interest Coverage N/A Asset Turnover 0.00
Working Capital -5.33 M Tangible Book Value 3.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.07 Forward P/E -3.91
P/B Ratio 7.29 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 5.42 Fwd Earnings Yield N/A
FCF Yield -22.64%
Market Cap 122.39 M Enterprise Value 119.69 M
Per Share
EPS (Diluted TTM) -0.63 Revenue / Share 0.00
FCF / Share -0.44 OCF / Share -0.43
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92.19%
SBC-Adj. FCF -31.98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 — — —
Net Income -30.05 M -21.68 M -14.65 M -22.66 M -38.30 M
EPS (Diluted) -0.63 -1.21 — — —
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 20.53 M 13.34 M 9.31 M 15.17 M 11.82 M
SG&A Expenses — — — — —
D&A 71,265.0 116,710.0 — — —
Interest Expense 625,283.0 4.14 M — 30,000.0 30,000.0
Income Tax 1,600.0 3,768.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 27.35 M 19.97 M 3.98 M 15.95 M 13.54 M
Total Liabilities 6.42 M 5.37 M 3.25 M 4.15 M 2.96 M
Shareholders' Equity 20.93 M 14.59 M 731,000.0 11.80 M 10.58 M
Total Debt — — — — —
Cash & Equivalents 3.62 M 12.66 M 1.54 M 11.78 M 10.54 M
Current Assets 4.62 M 19.61 M 3.27 M 13.26 M 11.79 M
Current Liabilities 5.92 M 5.33 M 3.08 M 3.99 M 2.78 M